ADVA Biotechnologies
Dr. Paldus is the chair of Sekhmet Ventures and the general partner of Skymoon Ventures. Former Founder, chairman, and CEO of Finesse Solutions Inc., a leading bioreactor company recently sold to ThermoFisher Scientific. Dr. Paldus was the former founder and CTO of Picarro. Dr. Paldus earned her Ph.D. in electronic engineering from Stanford University. Dr. Paldus has extensive understanding in the field of biotechnology, bioreactors, and strong and relevant business experience.
This person is not in the org chart
This person is not in any offices
ADVA Biotechnologies
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution.ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability,reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.